Evercore Group L.L.C. acted as financial advisor to Merck in this transaction and Covington & Burling LLP acted as its legal advisor. Centerview Partners LLC acted...
You must be a Standard 1 Year member to access this content.
Goodwin advised Human Immunology Biosciences (HI-Bio) on the round. Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs),...
You must be a Standard 1 Year member to access this content.
Goodwin advised SpringWorks Therapeutics, Inc. on the offering. American precision medicine company SpringWorks Therapeutics (Nasdaq: SWTX) has closed a public offering of 10,905,171 shares of its common...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
You must be a Standard 1 Year member to access this content.
Goodwin advised Scholar Rock Holding Corporation on the offering. Scholar Rock Holding Corporation (Nasdaq: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious...
You must be a Standard 1 Year member to access this content.
Goodwin advised Charm Industrial on the fundraising. Charm Industrial announced its $100 million Series B Preferred Stock financing. The round was led by General Catalyst with...
You must be a Standard 1 Year member to access this content.
Goodwin advised GaeaStar on the deal. GaeaStar announced its $6.5 million seed funding round. The round was led by a family office focused on ethical investments and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Wellth, Inc. on the deal. Wellth, Inc. announced its $20 million Series B financing round led by SignalFire. Headquartered in Los Angeles, California,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised BridgeBio Pharma on the offering, and Latham & Watkins advised the underwriters involved. BridgeBio Pharma, Inc. announced the pricing on March 7, 2023 of...
You must be a Standard 1 Year member to access this content.
Goodwin advised Shifted Energy on the deal. Shifted Energy announced its $4.3 million seed funding round, which will help the company expand its energy efficiency solutions and...
You must be a Standard 1 Year member to access this content.
Goodwin advised the joint underwriters on the deal. NAPCO Security Technologies, Inc. (NASDAQ: NSSC), one of the leading manufacturers and designers of high-tech electronic security devices,...
You must be a Standard 1 Year member to access this content.
Goodwin advised nxyz on the deal. Nxyz announced its $40 million Series A financing round. nxyz is a web3 platform that enables lightning-fast data infrastructure for blockchains....
You must be a Standard 1 Year member to access this content.
